248 | MATCHING‐ADJUSTED INDIRECT COMPARISON OF EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE VERSUS LISOCABTAGENE MARALEUCEL IN SECOND‐LINE FOLLICULAR LYMPHOMA
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
10.1002/hon.70094_248